CL2018002644A1 - Oclusión fístula pancreática. - Google Patents

Oclusión fístula pancreática.

Info

Publication number
CL2018002644A1
CL2018002644A1 CL2018002644A CL2018002644A CL2018002644A1 CL 2018002644 A1 CL2018002644 A1 CL 2018002644A1 CL 2018002644 A CL2018002644 A CL 2018002644A CL 2018002644 A CL2018002644 A CL 2018002644A CL 2018002644 A1 CL2018002644 A1 CL 2018002644A1
Authority
CL
Chile
Prior art keywords
pancreatic fistula
self
assembling peptide
occlusion
pancreatic
Prior art date
Application number
CL2018002644A
Other languages
English (en)
Spanish (es)
Inventor
Satoru Kobayashi
Original Assignee
3 D Matrix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3 D Matrix Ltd filed Critical 3 D Matrix Ltd
Publication of CL2018002644A1 publication Critical patent/CL2018002644A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0015—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0031—Hydrogels or hydrocolloids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
CL2018002644A 2016-03-18 2018-09-14 Oclusión fístula pancreática. CL2018002644A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662310124P 2016-03-18 2016-03-18

Publications (1)

Publication Number Publication Date
CL2018002644A1 true CL2018002644A1 (es) 2019-07-05

Family

ID=58672629

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2018002644A CL2018002644A1 (es) 2016-03-18 2018-09-14 Oclusión fístula pancreática.

Country Status (9)

Country Link
US (1) US20200078489A1 (OSRAM)
EP (1) EP3429646A1 (OSRAM)
JP (1) JP2019508175A (OSRAM)
CN (1) CN109152861A (OSRAM)
AU (1) AU2017235871A1 (OSRAM)
BR (1) BR112018068838A2 (OSRAM)
CL (1) CL2018002644A1 (OSRAM)
MX (1) MX2018011120A (OSRAM)
WO (1) WO2017158432A1 (OSRAM)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12377196B2 (en) 2016-03-18 2025-08-05 3-D Matrix, Ltd. Preventing biological tissue adhesion

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6912953B2 (ja) * 2016-06-27 2021-08-04 三洋化成工業株式会社 体液漏出防止剤
US20210220429A1 (en) * 2018-10-05 2021-07-22 Kurume University Pharmaceutical composition for treating or preventing ulcer or fistula in intestinal tract
WO2021171846A1 (ja) * 2020-02-28 2021-09-02 株式会社メニコン 消化液漏出防止材および消化液による消化からの器官保護材
EP4125995A4 (en) 2020-03-31 2024-04-10 3-D Matrix, Ltd. STERILIZATION OF SELF-ASSEMBLY PEPTIDES BY IRRADIATION
CN111939323B (zh) * 2020-08-08 2022-06-10 武汉速普生物科技有限公司 含有透明质酸连接肽和连接蛋白末端肽的功能性多肽水凝胶及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5204646B2 (ja) * 2005-04-25 2013-06-05 マサチューセッツ インスティテュート オブ テクノロジー 止血および他の生理学的活性を促進するための組成物および方法
WO2009049022A1 (en) * 2007-10-10 2009-04-16 Ore Pharmaceuticals Inc. Method for treatment of pancreatitis
US10576123B2 (en) * 2008-10-06 2020-03-03 3-D Matrix, Ltd. Tissue occluding agent comprising an IEIKIEIKIEIKI peptide
WO2014141160A1 (en) * 2013-03-14 2014-09-18 3-D Matrix, Ltd Treatment for bile leakage
CN105342984A (zh) * 2014-08-21 2016-02-24 中国人民解放军总医院 一种用于治疗急性胰腺炎的可注射温敏凝胶制剂

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12377196B2 (en) 2016-03-18 2025-08-05 3-D Matrix, Ltd. Preventing biological tissue adhesion

Also Published As

Publication number Publication date
JP2019508175A (ja) 2019-03-28
EP3429646A1 (en) 2019-01-23
WO2017158432A1 (en) 2017-09-21
US20200078489A1 (en) 2020-03-12
AU2017235871A1 (en) 2018-09-27
BR112018068838A2 (pt) 2019-01-22
CN109152861A (zh) 2019-01-04
MX2018011120A (es) 2019-03-28

Similar Documents

Publication Publication Date Title
CL2018002644A1 (es) Oclusión fístula pancreática.
MX2020004883A (es) Composiciones de exosomas modificados y metodos de cargar cargas de exosomas luminales.
CO2019005464A1 (es) Dispositivo para aneurisma y sistema de suministro
CO2018004564A2 (es) Genes de ataxia de friedreich modificados y vectores para terapia génica
AR088044A1 (es) Proteinas de fusion para tratar trastornos metabolicos
CO2020001627A2 (es) Composiciones de aminoácidos para el tratamiento de lesión neuronal
MX387560B (es) Procedimiento para mejorar la solubilidad de proteínas y péptidos usando un enlace del fragmento fc de inmunoglobulina.
MX2018011491A (es) Disposiciones de secuencia y secuencias para presentacion de neoepitopos.
MX387816B (es) Dispositivos para estabilización de articulación y hueso de tensión activa.
MX2016013803A (es) Manufactura de neurotoxinas del clostridium botulinum recombinantes.
UY35444A (es) Anticuerpos anti-tnf alfa mutados y métodos para su utilización
PE20160243A1 (es) Polipeptido para la escision hidrolitica de la zearalenona y/o derivados de la zearalenona, polinucleotido aislado de la misma y polieptido que contiene aditivo, uso y procedimiento de los mismos
MX2017009595A (es) Compuestos antisenescentes y usos de los mismos.
BR112018001292A2 (pt) métodos para melhor liberação de agentes ativos a tumores
BR112016016274A2 (pt) Ponte da barreira hematoencefálica
MX2019001633A (es) Proteina derivada de la seda para el tratamiento de la inflamacion.
AR105089A1 (es) ANTICUERPOS ANTI-TAU(pS422) HUMANIZADOS Y MÉTODOS DE UTILIZACIÓN
AR120721A2 (es) Péptidos y composiciones para el tratamiento de daño articular
BR112018001435A2 (pt) métodos para entrega linfática de agentes ativos
MX2016008108A (es) Angiotensina ii sola o en combinacion para el tratamiento de hipotension.
CL2018002646A1 (es) Prevención de la adherencia del tejido biológico.
CL2020000733A1 (es) Proteína de fusión que comprende una porción de fgf-18.
CL2017003144A1 (es) Péptidos lipidados resistentes a proteasas
PE20151866A1 (es) Composiciones nutricionales que contienen un componente peptidico con propiedades estimulantes de adiponectina y usos del mismo
MX2019005979A (es) Peptidos modificados.